Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Accelerated Approval: Avastin, Makena Bookend A Watershed Decade For US FDA’s Expedited Pathway
Apr 28 2020
•
By
Sue Sutter
Avastin and Makena became bookends for US FDA's accelerated approval program in the last decade. • Source: Shutterstock
More from Review Pathways
More from Pathways & Standards